Global Public Health Insurance Market Outlook, 2031
The Global Public Health Insurance Market is anticipated to grow, driven by increasing government initiatives to expand healthcare coverage and the rising demand for affordable med
If you purchase this report now and we update it in next 100 days, get it free!
The global public health insurance industry covers government-run or government-mandated health coverage programmes that finance medical care for citizens and residents, including social health insurance systems funded by payroll contributions, tax-funded national health insurance and health services, and targeted programmes for older, low-income, disabled or other specific populations. Major programmes include Medicare and Medicaid in the United States; Germany's statutory health insurance, covering about 90% of the population through more than 90 sickness funds; France's Assurance Maladie; Japan's national health insurance and employee health insurance; South Korea's National Health Insurance Service; Taiwan's National Health Insurance; China's basic medical insurance system, covering about 1.3 billion people through employee and urban-rural resident schemes; India's Ayushman Bharat Pradhan Mantri Jan Arogya Yojana, which covers hospital care for hundreds of millions of lower-income people; Brazil's Unified Health System; Mexico's public programmes; Thailand's Universal Coverage Scheme; and national health services funded by taxation in the UK, Nordic countries, Spain, Italy and Canada's provincial plans. Public programmes pay providers directly or through contracted private insurers and administrators, and they set prices, benefits and rules that shape entire healthcare markets.
Public health insurance programmes face pressure from ageing populations, rising costs of new treatments and constrained public budgets. In the United States, several major changes have taken effect since 2024. The Inflation Reduction Act capped out-of-pocket drug costs for Medicare Part D enrollees at USD 2,000 from 2025, and the first Medicare negotiated drug prices took effect in January 2026, with a second round announced in November 2025. The One Big Beautiful Bill Act, signed in July 2025, introduced work requirements for many Medicaid adults from 2027, more frequent eligibility checks and limits on provider taxes, changes the Congressional Budget Office estimated would cut federal Medicaid spending by roughly USD 1 trillion over a decade and increase the number of uninsured people, while providing USD 50 billion for rural health. Medicare Advantage, in which private insurers administer Medicare benefits, received a 2.48% payment increase for 2027 in April 2026. In India, the government expanded Ayushman Bharat in October 2024 to cover all citizens aged 70 and older regardless of income. In Germany, statutory health insurance funds raised average supplementary contribution rates in 2025 and 2026 amid deficits, and in China the national healthcare security administration has used volume-based procurement and payment reforms to control costs. Many countries are also reforming provider payment toward diagnosis-related groups and value-based models.
What's Inside a Bonafide Research`s industry report?
A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.
Market DynamicsMarket Drivers • Universal Health Coverage CommitmentsGovernments worldwide have committed to universal health coverage, reaffirmed in the UN political declaration of 2023, and are expanding public insurance to more people and services. Countries including India, Indonesia, the Philippines, Vietnam, Nigeria, Kenya and Egypt are extending public insurance schemes, while high-income countries maintain and adapt universal systems. Public insurance reduces financial hardship and improves access to care.
• Ageing Populations and Chronic DiseaseOlder people use far more healthcare, and ageing populations in Europe, East Asia and North America increase demand on public programmes such as Medicare, Japan's insurance for older people and European social insurance. Chronic diseases, including diabetes, heart disease and cancer, require long-term treatment funded by public programmes. These trends increase the scale and importance of public health insurance.
Market Challenges • Financial Sustainability and Budget PressurePublic health insurance spending is growing faster than economies and payroll bases in many countries, driven by ageing, new technologies, expensive medicines and workforce costs. Programmes face deficits, as in Germany's sickness funds and the projected depletion of the US Medicare hospital insurance trust fund in the 2030s. Governments must choose between raising contributions or taxes, cutting benefits, controlling prices or tightening eligibility.
• Access Gaps, Waiting Times and Political ChangePublic coverage does not always ensure timely access, with long waiting lists in the UK, Canada and other systems, and gaps in coverage for dental, vision and long-term care. In many low- and middle-income countries, public schemes have limited benefits and high out-of-pocket costs remain. Political changes, such as US Medicaid reforms in 2025, can reduce coverage, and eligibility rules and administrative barriers can cause people to lose coverage.
Market Trends • Drug Price Negotiation and Strategic PurchasingPublic payers are using their purchasing power to control drug and device costs, including Medicare drug price negotiation in the United States, China's volume-based procurement and national reimbursement drug list negotiations, health technology assessment in Europe, Japan's regular price revisions and India's price controls. Joint procurement among countries and outcomes-based agreements for high-cost therapies are also expanding.
• Payment Reform and Digital AdministrationPublic programmes are shifting from fee-for-service to diagnosis-related group payments, capitation and value-based payments that reward quality and efficiency. China has moved hospitals to DRG and DIP payment systems, the United States operates value-based models through CMS, and European countries refine case-based payments. Digital health IDs, electronic claims, AI-based fraud detection and online enrollment are improving administration.
Make this report your own
Have queries/questions regarding a report
Take advantage of intelligence tailored to your business objective
Sikandar Kesari
Research Analyst
Segment AnalysisSocial health insurance and tax-funded national systems cover the largest share of people with public health coverage, while targeted programmes for older and low-income people account for large shares of spending in specific countries. Social health insurance systems, funded mainly by payroll contributions from employers and employees and administered by sickness funds or national agencies, cover most people in Germany, France, the Netherlands, Belgium, Japan, South Korea, Taiwan, China and many Latin American countries. Tax-funded national health services and national health insurance, including the UK's NHS, Nordic systems, Spain, Italy, Canada's provincial plans and Australia's Medicare, cover entire populations through general taxation. Programmes for older people, such as US Medicare and Japan's late-stage elderly medical care system, account for large shares of spending because of high healthcare use. Programmes for low-income people, such as US Medicaid and the Children's Health Insurance Program, India's Ayushman Bharat PM-JAY and similar schemes in Indonesia, the Philippines and Africa, target those most in need. Programmes for specific groups, such as military and veterans' health systems and civil servants' schemes, serve particular populations. Community-based and subsidised health insurance schemes in low-income countries extend coverage to informal workers.
Hospital and inpatient care accounts for the largest share of public health insurance spending, while pharmaceuticals, outpatient care and long-term care are major and growing components. Hospital and inpatient care, including surgery, emergency care and intensive care, accounts for the largest share of public health insurance spending in most countries, and many public schemes in low- and middle-income countries, including India's PM-JAY, focus mainly on hospital coverage. Outpatient and primary care, including physician visits, diagnostics and preventive services, is covered by comprehensive systems. Prescription drugs form a large and growing share of spending, driven by specialty medicines, and public payers increasingly negotiate prices and use formularies. Long-term care, including nursing homes and home care, is covered by separate public insurance in countries such as Germany, Japan, South Korea and the Netherlands, and by Medicaid in the United States, and spending is rising with ageing. Mental health services are increasingly covered, although access remains limited. Maternity and child health services are core benefits in most systems. Dental, vision and hearing coverage varies widely and is often limited for adults. Medical devices and rehabilitation form further components.
Government agencies administer most public health insurance directly, while contracted private insurers and administrators manage significant parts of some programmes. Government agencies, including national health insurance agencies in Japan, South Korea, Taiwan and China, national health services in the UK and Nordic countries, and CMS for traditional Medicare, administer public health insurance directly, setting rules, paying providers and managing budgets. Statutory sickness funds, such as Germany's Allgemeine Ortskrankenkassen and Techniker Krankenkasse and France's Assurance Maladie funds, are public or quasi-public bodies that collect contributions and pay for care. Contracted private insurers administer significant parts of public programmes in some countries, including Medicare Advantage and Medicare Part D plans, Medicaid managed care organisations in the United States, and insurers and third-party administrators contracted under India's PM-JAY in some states. Regional and state governments administer programmes in federal systems, such as US states for Medicaid, Canadian provinces and Spanish and Italian regions. Third-party administrators and IT providers support claims processing and enrollment. The use of private administrators in public programmes is debated, with supporters citing efficiency and choice and critics citing costs and access restrictions.
Don't pay for what you don't need. Save 30%
Customise your report by selecting specific countries or regions
Payroll contributions and general taxation are the main sources of public health insurance funding, supplemented by premiums, cost-sharing and earmarked taxes. Payroll contributions from employers and employees fund social health insurance systems in Germany, France, Japan, South Korea, China's employee scheme and many others, linking funding to employment and wages. General taxation funds national health services and tax-based systems in the UK, Nordic countries, Canada, Australia and Italy, and governments also subsidise social insurance systems from tax revenues to cover deficits and non-contributing groups such as children and the unemployed. Premiums paid by beneficiaries fund parts of some programmes, such as US Medicare Part B and Part D and resident schemes in China. Cost-sharing, including deductibles, copayments and coinsurance, is used to control demand and raise revenue, with protections for low-income and chronically ill people. Earmarked taxes, such as taxes on tobacco, alcohol and sugary drinks, fund health programmes in some countries. External funding from donors supports public health insurance development in some low-income countries. Rising costs have led to debates about raising contribution rates, as in Germany, or increasing tax funding.
Regional AnalysisEurope and East Asia have the most comprehensive public health insurance coverage, while North America accounts for the largest public health spending through Medicare and Medicaid and emerging markets are expanding coverage rapidly. North America, led by the United States, accounts for the largest public health insurance spending in absolute terms through Medicare, which covers about 68 million people, and Medicaid and CHIP, which cover roughly 80 million people. Major recent changes include the USD 2,000 cap on Part D out-of-pocket costs from 2025, the first negotiated drug prices from 2026, Medicaid reforms enacted in July 2025 including work requirements from 2027 and provider tax limits, and a 2.48% increase in Medicare Advantage payments for 2027. Canada's provincial plans cover hospital and physician services for all residents. Europe has universal coverage through social health insurance or national health services, with Germany's statutory insurance facing deficits and higher contribution rates, France's Assurance Maladie managing cost pressures, and the UK's NHS reorganising under its 10 Year Health Plan. East Asia has mature universal systems in Japan, South Korea and Taiwan, while China's basic medical insurance covers about 1.3 billion people and uses volume-based procurement and DRG payment reforms. India's PM-JAY, expanded in 2024 to all people aged 70 and over, is one of the world's largest public health insurance schemes by population. Southeast Asian countries, including Thailand, Indonesia, Vietnam and the Philippines, have expanded coverage toward universality. Latin America has public systems such as Brazil's SUS, and the Middle East and Africa are expanding national insurance schemes, including in Saudi Arabia, Egypt, Kenya, Nigeria and Ghana.
Key Developments April 2026: CMS finalised a 2.48% average payment increase for Medicare Advantage plans in 2027, about 5% including risk score trends, after delaying changes to its risk adjustment model.
January 2026: Medicare began paying negotiated prices for ten drugs under the Inflation Reduction Act, with a second round of 15 drugs, including semaglutide, taking effect in 2027.
July 2025: The One Big Beautiful Bill Act introduced Medicaid work requirements from 2027, more frequent eligibility checks and limits on provider taxes, reducing projected federal Medicaid spending.
January 2025: Annual out-of-pocket prescription drug costs for Medicare Part D enrollees were capped at USD 2,000 under the Inflation Reduction Act.
January 2025: Average supplementary contribution rates for Germany's statutory health insurance rose sharply as sickness funds faced large deficits from rising costs.
October 2024: India extended PM-JAY coverage of up to ₹5 lakh per family per year to all citizens aged 70 and over, regardless of income.
Considered in this report
• Historic Year: 2020
• Base Year: 2025
• Estimated Year: 2026
• Forecast Year: 2031
Aspects covered in this report
• Global Public Health Insurance Market with its value and forecast along with its segments
• Various drivers and challenges
• Ongoing trends and developments
• Top profiled companies
• Strategic recommendation
By Programme Type
• Social Health Insurance
• Tax-Funded National Systems
• Programmes for Older People
• Programmes for Low-Income People
• Programmes for Specific Groups
By Service Covered
• Hospital and Inpatient Care
• Outpatient and Primary Care
• Prescription Drugs
• Long-Term Care
• Mental Health
• Dental, Vision and Other
By Administrator
• Government Agencies
• Statutory Sickness Funds
• Contracted Private Insurers
• Regional and State Governments
By Funding Source
• Payroll Contributions
• General Taxation
• Beneficiary Premiums and Cost-Sharing
• Earmarked Taxes and Donor Funding
One individual can access, store, display, or archive the report in Excel format but cannot print, copy, or share it. Use is confidential and internal only. License information
One individual can access, store, display, or archive the report in PDF format but cannot print, copy, or share it. Use is confidential and internal only. License information
Up to 10 employees in one region can store, display, duplicate, and archive the report for internal use. Use is confidential and printable. License information
All employees globally can access, print, copy, and cite data externally (with attribution to Bonafide Research). License information